Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
65
IMPJY Quote, Financials, Valuation and Earnings
Last price:
$5.89
Seasonality move
:
1.13%
Day range:
$5.89 - $5.89
52-week range:
$3.79 - $5.89
Dividend yield:
2.61%
P/E ratio:
15.19x
P/S ratio:
0.27x
P/B ratio:
1.77x
Volume:
--
Avg. volume:
133
1-year change:
42.68%
Market cap:
$2.9B
Revenue:
$10.1B
EPS (TTM):
$0.39
Earnings Data
Next earnings date for IMPJY
--
Most recent earnings per share
-$0.04
Missed by $0.04
(Dec 31/2015)
Consensus Estimate
--
(Dec 31/2015)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IMPJY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2015 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $0.07 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $0.02 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | $0.22 | -- | -- |
| 12/31/2014 | Q4 | -- | -- | -$0.07 | -- | -- |
WeBuild SpA Earnings Questions
-
How Much did WeBuild SpA Generate in Revenue Last Quarter?
WeBuild SpA reported -- worth of top line sales in its most recent quarter.
-
Did WeBuild SpA Beat Earnings Last Quarter?
WeBuild SpA announced earnings per share of -$0.04 which represents a miss of analyst forecast a -- per share.
-
Is WeBuild SpA Profitable?
WeBuild SpA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for WeBuild SpA EPS Next Year?
WeBuild SpA's earnings are forecast to grow from $0.28 per share to -- per share next year representing an increase of --.
-
When is WeBuild SpA's Earnings Date?
Currently, WeBuild SpA has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
